(Total Views: 122)
Posted On: 06/27/2023 1:55:56 PM
Post# of 14

$NRBO News Article - NeuroBo Pharmaceuticals' Novel GLP1R and GCGR Dual Agonist, DA-1726, Shown to Elicit Superior Weight Loss Efficacy Compared to Semaglutide and Tirzepatide in Preclinical Models https://marketwirenews.com/news-releases/neur...50413.html


My Twitter: WhyteStocks